Apr 17, 2021

Featuring perspectives from Drs Joel W Neal and Paul K Paik on the following topics:

• Introduction (0:00)
• Case: A 67-year-old man, never smoker with symptomatic metastatic adenosquamous carcinoma of the lung (1:33)
• Targeting ROS1 rearrangements in non-small cell lung cancer (NSCLC) (9:07)
• EGFR exon 19 deletion and exon 21 (L858R) point mutation in NSCLC (11:17)
• Recent data with agents targeting EGFR exon 20 insertions in NSCLC (28:22)
• Efficacy and safety of agents targeting HER2 amplification/mutation (31:56)
• ALK rearrangements as a therapeutic target in NSCLC (38:07)
• Targeting NTRK fusions in NSCLC (41:46)
• Available data with RET inhibitors in NSCLC (43:50)
• MET Exon 14 skipping mutations in NSCLC (46:36)
• Emerging data with agents targeting KRAS G12C mutation in NSCLC (51:47)

CME information and select publications